The ONELAB EU project has launched a flash survey to explore awareness and acceptance of mass testing for pathogens. Inputs are needed to gather our perception. You can donate 5min of your time by answering and sharing. Available in 5 languages. ENG here
https://t.co/Z67Lc3lSC0
HPV-vaccinated women have a much lower lifetime risk of CIN3+ (as low as 0.5% with the nonavalent vaccine), supporting less intensive screening—just 2 lifetime screens vs. 7 for unvaccinated. Time to tailor protocols.
📎 @FInturrisi
🔗 https://t.co/wBoot6ox12
#HPV#CervicalCancer
Top Viewed Article! My article published in the IJC on behalf of Union for International #Cancer Control has received Wiley's certification as Top Viewed Article. https://t.co/ClEtluLRNw #TopViewedArticle@wileyinresearch@uicc@IntJCanc
🌳 The air we breathe.
🍎 The food we eat.
💧 The water we drink.
🌇 The environment we live in.
All of these factors impact human health.
To ensure #HealthForAll, we must first protect nature and safeguard our one and only planet. 🌎via @WHO
Last chance to register for IPVS educational webinar tomorrow ! Hear about the PAVE approach for #cervicalcancer screening in low-resource settings. Ask your questions to the panel.
Sign up now ➡️ https://t.co/4EftiVax4l
#CancerResearch#HPV
Our new HPW piece addresses the use of HPV typing as part of the transition from subjective to objective methods for #screening and #prevention of #cervicalcancer : "Optimizing cervical cancer screening management through HPV extended genotyping" @theNCI https://t.co/vUPRVGs3LQ
🌐 Estimated lifetime CIN3+ risk in #HPV vaccinated cohorts is significantly reduced.
💉 Results suggest potential de-intensification of screening programs in contexts with high vaccination coverage. @FInturrisi@IntJCanc
🔗 https://t.co/Nz9c7zTPmz
Read about the experience of one of the recipients of the Early Career Research Training Award in 2023, Federica Inturrisi @FInturrisi . 🤩
Apply for the second edition of the Award in 2024 by 15 February ➡️ https://t.co/l40QWgLCA8
Did you know that 5% of all cancers worldwide are caused by #HPV?
You can take action to tackle this virus! Get informed➡️Get Vaccinated➡️Get Screened
For #HPVAwarenessDay, learn more about HPV: https://t.co/UfZptWJlD9
If we increase HPV vaccination coverage and screening coverage to #CloseTheCareGap , we can save millions of lives to cervical cancer and will soon be able to de-intensify screening
🌐 Estimated lifetime CIN3+ risk in #HPV vaccinated cohorts is significantly reduced.
💉 Results suggest potential de-intensification of screening programs in contexts with high vaccination coverage. @FInturrisi@IntJCanc
🔗 https://t.co/Nz9c7zTPmz
It's #CervicalCancerAwarenessMonth! Around 604,000 women are diagnosed with #cervicalcancer and 342,000 women die from the disease globally each year.
Cervical cancer is the most common cancer death among women in 36 countries - mostly in sub-Saharan Africa🌍 and Latin America🌎
Men are at higher risk of cancer than women, BUT...women represent the majority of deaths, cancer workforce, orphans caregivers, pharmacists, nurses, community healthcare workers, etc. Live "The global launch of #Women, power and #cancer: A @TheLancet Commission". @NIH#Equality
Lawrence Lacks’ passing leaves a big void in the movement for social justice. We are comforted by the honor @WHO bestowed on the family & by his legacy in the fight for no child to lose a mother to #CervicalCancer. Our prayers are with the @LacksFamily@CELLebrateHeLa.
@DrTedros
Register to attend the global launch of #Women, power, & #cancer: A @TheLancet Commission!
The ceremony will take place at 14:00 – 16:30 CEST on 27 September at The Geneva Graduate Institute, Geneva.
Register below to attend virtually: https://t.co/6t8f6aYSwH.